Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on May 4, 2016. The report details a corporate governance action taken by the Board of Directors on the same date regarding the Company's Amended and Restated By-laws.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a legal amendment and does not contain financial performance data.
Material Changes
The Board of Directors approved an amendment to Article XII, Section 12.01 of the By-laws, effective immediately. The amendment deletes the "Litigation Costs" provision. Previously, this provision required a "Claiming Party" to reimburse the Company and its directors, officers, or employees for all fees and expenses if the party initiated a "Covered Proceeding" (such as derivative actions or fiduciary duty claims) and failed to obtain a judgment substantially achieving the full remedy sought.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The removal of the litigation cost reimbursement provision may be viewed as a change in the Company's approach to shareholder litigation risks, potentially reducing barriers for shareholders to bring claims against the Company or its leadership.
Key Facts for Investor Verification
- The Company removed a by-law provision that mandated unsuccessful litigants to reimburse the Company for legal costs.
- The amendment was approved by the Board of Directors on May 4, 2016, and is effective immediately.
- The full text of the Amended and Restated By-laws is attached as Exhibit 3.1 to this filing.
- No financial results or operational metrics are disclosed in this specific report.